{
  "id": "Tisdale_Risk_Score_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2021-01-13",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To assist clinicians to predict risk of QT prolongation greater than 500 msec.",
        "keywords": [
          "QT",
          "QTc",
          "Acute myocardial infarction",
          "Prolongation"
        ],
        "use": "Use in in hospitalized patients.\n\nTisdale Risk Score and assigned points: \n1. Age ≥68 years: No=0, Yes=1\n2. Sex: No=0, Yes=1\n3. Patient on loop diuretic: No=0, Yes=1\n4. Potassium* ≤3.5 mEq/L: No=0, Yes=2\n*Potassium should be potassium determined closest to EKG timing.\n5. Admission QTc** ≥450 msec\n**Auto-calculated by EKG.\n6. Being admitted for acute myocardial infarction: No=0, Yes=2\n7. Being admitted for sepsis: No=0, Yes=3\n8. Being admitted for heart failure: No=0, Yes=3\n9. Number of QTc-prolonging drugs given***: No=0, 1 QTc-prolonging drug=3, ≥2 QTc-prolonging drugs=6\n***If receiving ≥2 drugs, patient receives 3 points for 1 QTc-prolonging drug as well as 3 additional points for ≥2.\nTisdale Risk Score formula: \nTisdale Risk Score interpretation= Addition of the selected points.\n\nTisdale Risk Score interpretation:\n\nTisdale Risk Score     Risk for QT prolongation             Recommendation\n≤6                                Low                                            Always consider that higher risk may develop depending on clinical course and drug                                                                                             \n                                                                                       interactions and pharmacokinetics.\n\n7-10                              Moderate                                     Consider consultation with pharmacist, adjusting risk factors as much as possible. EKG                                                                                              \n                                                                                          should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. \n\n≥11                               High                                              Consider consultation with pharmacist, adjusting risk factors as much as possible, and using                                                                                              \n                                                                                          alternative medications if possible. EKG should be repeated after 5 half-lives of QT-                                                                                             \n                                                                                          prolonging drugs given to evaluate QTc. ",
        "misuse": "Not to use to predict outpatient risk of QT prolongation. This score does not consider dosing adjustments for renally-eliminated drugs.",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479-87.\n2. Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2014;7:381-390.\n3. Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-52."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.tisdale_risk.v0",
        "template_id": "openEHR-EHR-OBSERVATION.tisdale_risk.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0022]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0025]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0028]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0032]"
          }
        }
      },
      "gt0012": {
        "id": "gt0012",
        "model_id": "openEHR-EHR-OBSERVATION.tisdale_risk.v0",
        "template_id": "openEHR-EHR-OBSERVATION.tisdale_risk.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0037]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0038]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0039]"
          }
        }
      }
    },
    "rules": {
      "gt0017": {
        "id": "gt0017",
        "priority": 4,
        "when": [
          "$gt0003|Age ≥68 years|!=null",
          "$gt0004|Sex|!=null",
          "$gt0005|Patient on loop diuretic|!=null",
          "$gt0006|Potassium ≤3.5 mEq/L|!=null",
          "$gt0007|Admission QTc ≥450 msec|!=null",
          "$gt0008|Being admitted for acute myocardial infarction|!=null",
          "$gt0009|Being admitted for sepsis|!=null",
          "$gt0010|Being admitted for heart failure|!=null",
          "$gt0011|Number of QTc-prolonging drugs given|!=null"
        ],
        "then": [
          "$gt0014|Tisdale Risk Score for QTc|.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value+$gt0011.value"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 3,
        "when": [
          "$gt0014|Tisdale Risk Score for QTc|<=6"
        ],
        "then": [
          "$gt0015|Risk for QT prolongation|=local::at0040|Low risk for QT prolongation|",
          "$gt0016|Recommendation|=local::at0043|Always consider that higher risk may develop depending on clinical course and drug interactions and pharmacokinetics.|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 2,
        "when": [
          "$gt0014|Tisdale Risk Score for QTc|>6",
          "$gt0014|Tisdale Risk Score for QTc|<11"
        ],
        "then": [
          "$gt0015|Risk for QT prolongation|=local::at0041|Moderate risk for QT prolongation|",
          "$gt0016|Recommendation|=local::at0044|Consider consultation with pharmacist, adjusting risk factors as much as possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 1,
        "when": [
          "$gt0014|Tisdale Risk Score for QTc|>=11"
        ],
        "then": [
          "$gt0015|Risk for QT prolongation|=local::at0042|High risk for QT prolongation|",
          "$gt0016|Recommendation|=local::at0045|Consider consultation with pharmacist, adjusting risk factors as much as possible, and using alternative medications if possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Tisdale Risk Score",
            "description": "Tisdale Risk Score for QT Prolongation."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Age ≥68 years",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Sex",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Patient on loop diuretic",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Potassium ≤3.5 mEq/L",
            "description": "Potassium should be potassium determined closest to EKG timing"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Admission QTc ≥450 msec",
            "description": "Auto-calculated by EKG"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Being admitted for acute myocardial infarction",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Being admitted for sepsis",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Being admitted for heart failure",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Number of QTc-prolonging drugs given",
            "description": "If receiving ≥2 drugs, patient receives 3 points for 1 QTc-prolonging drug as well as 3 additional points for ≥2\r\n"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Is this a COVID-19 patient?",
            "description": "For research purposes only; answer does NOT impact results.\r\n"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Tisdale Risk Score for QTc",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Risk for QT prolongation",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Recommendation",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Tisdale Risk Score"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Interpretation to score <=6"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Interpretation to score 7-10"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Interpretation to score>=11"
          }
        }
      }
    }
  }
}